About National Health Investors (NYSE:NHI)
National Health Investors, Inc. is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties. Its portfolio consists of lease, mortgage and other note investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, specialty hospitals and medical office buildings. Its other investments include marketable securities and a joint venture structured to comply with the provisions of the REIT Investment Diversification Empowerment Act of 2007 (RIDEA) through which it invests in facility operations managed by an independent third party. As of December 31, 2016, it had investments in real estate, mortgage and other notes receivable involving 205 facilities located in 32 states.
Industry, Sector and Symbol:
- Sector: Finance
- Industry: Healthcare REITs
- Sub-Industry: Specialized REITs
- Symbol: NYSE:NHI
- CUSIP: 63633D10
- Web: www.nhireit.com
- Market Cap: $3.19 billion
- Outstanding Shares: 40,986,000
- 50 Day Moving Avg: $78.48
- 200 Day Moving Avg: $77.02
- 52 Week Range: $66.31 - $81.21
Sales & Book Value:
- Trailing P/E Ratio: 20.01
- Foreward P/E Ratio: 20.95
- P/E Growth: 2.01
- Annual Revenue: $263.75 million
- Price / Sales: 12.11
- Book Value: $31.39 per share
- Price / Book: 2.48
- Annual Dividend: $3.80
- Dividend Yield: 4.9%
- EBITDA: $257.02 million
- Net Margins: 59.24%
- Return on Equity: 12.56%
- Return on Assets: 6.38%
- Debt-to-Equity Ratio: 0.89%
- Current Ratio: 12.45%
- Quick Ratio: 12.45%
- Average Volume: 195,220 shs.
- Beta: 0.56
- Short Ratio: 5.93
Frequently Asked Questions for National Health Investors (NYSE:NHI)
What is National Health Investors' stock symbol?
National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI."
How often does National Health Investors pay dividends? What is the dividend yield for National Health Investors?
National Health Investors declared a quarterly dividend on Wednesday, August 9th. Stockholders of record on Friday, September 29th will be paid a dividend of $0.95 per share on Friday, November 10th. This represents a $3.80 dividend on an annualized basis and a dividend yield of 4.88%. The ex-dividend date is Thursday, September 28th. View National Health Investors' Dividend History.
How were National Health Investors' earnings last quarter?
National Health Investors, Inc. (NYSE:NHI) announced its earnings results on Wednesday, August, 9th. The company reported $0.93 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.29 by $0.36. The business earned $69.84 million during the quarter, compared to the consensus estimate of $67.68 million. National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. National Health Investors's revenue was up 14.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.22 earnings per share. View National Health Investors' Earnings History.
When will National Health Investors make its next earnings announcement?
What guidance has National Health Investors issued on next quarter's earnings?
National Health Investors updated its FY17 earnings guidance on Wednesday, August, 9th. The company provided EPS guidance of $5.22-5.26 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.18.
Where is National Health Investors' stock going? Where will National Health Investors' stock price be in 2017?
7 brokerages have issued twelve-month target prices for National Health Investors' stock. Their forecasts range from $75.00 to $82.00. On average, they anticipate National Health Investors' stock price to reach $79.17 in the next twelve months. View Analyst Ratings for National Health Investors.
Who are some of National Health Investors' key competitors?
Some companies that are related to National Health Investors include Omega Healthcare Investors (OHI), Healthcare Trust of America (HTA), Medical Properties Trust (MPW), Healthcare Realty Trust Incorporated (HR), Sabra Healthcare REIT (SBRA), Physicians Realty Trust (DOC), LTC Properties (LTC), CareTrust REIT (CTRE), Universal Health Realty Income Trust (UHT), Assura PLC (AGR), Primary Health Properties PLC (PHP), MedEquities Realty Trust (MRT), Community Healthcare Trust Incorporated (CHCT), Aviv REIT (AVIV), Care Capital Properties (CCP) and Global Medical REIT (GMRE).
Who are National Health Investors' key executives?
National Health Investors' management team includes the folowing people:
- D Eric Mendelsohn, President, Chief Executive Officer
- John L. Spaid, Executive Vice President - Finance
- Kevin Carlton Pascoe, Executive Vice President - Investments, Chief Investment Officer
- Roger R. Hopkins, Chief Accounting Officer
- Kristin S. Gaines, Chief Credit Officer
- James R. Jobe, Independent Director
- Robert T. Webb, Independent Director
How do I buy National Health Investors stock?
Shares of National Health Investors can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is National Health Investors' stock price today?
MarketBeat Community Rating for National Health Investors (NYSE NHI)MarketBeat's community ratings are surveys of what our community members think about National Health Investors and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of National Health Investors stock can currently be purchased for approximately $77.92.
Consensus Ratings for National Health Investors (NYSE:NHI) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Sell Rating, 5 Hold Ratings, 1 Buy Rating|
|Consensus Rating:||Hold (Score: 2.00)|
|Consensus Price Target: ||$79.17 (1.60% upside)|Consensus Price Target History for National Health Investors (NYSE:NHI)
Analysts' Ratings History for National Health Investors (NYSE:NHI)
(Data available from 10/22/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|10/18/2017||BMO Capital Markets||Reiterated Rating||Hold||$80.00||N/A|
|10/10/2017||SunTrust Banks, Inc.||Initiated Coverage||Hold||$80.00||N/A|
|10/4/2017||Stifel Nicolaus||Reiterated Rating||Buy||$82.00||Low|
|5/22/2017||Bank of America Corporation||Downgrade||Neutral -> Underperform||$76.00||Low|
|2/21/2017||Cantor Fitzgerald||Reiterated Rating||Neutral||$75.00||N/A|
|9/4/2016||Wells Fargo & Company||Reiterated Rating||Hold||N/A|
|6/4/2016||JMP Securities||Reiterated Rating||Hold||N/A|
Earnings History for National Health Investors (NYSE:NHI)Earnings History by Quarter for National Health Investors (NYSE NHI)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/9/2017||Q2 2017||$1.29||$0.93||$67.68 million||$69.84 million||View||Listen|
|5/9/2017||Q1 2017||$1.26||$1.10||$65.42 million||$66.39 million||View||Listen|
|2/17/2017||Q416||$0.87||$1.03||$64.88 million||$65.00 million||View||N/A|
|11/7/2016||Q316||$1.25||$1.23||$62.39 million||$63.30 million||View||Listen|
|8/5/2016||Q216||$1.21||$1.22||$58.08 million||$61.20 million||View||N/A|
|5/6/2016||Q116||$1.17||$1.16||$57.81 million||$59.02 million||View||N/A|
|2/18/2016||Q415||$1.17||$1.17||$57.20 million||$54.40 million||View||Listen|
|11/5/2015||Q315||$1.17||$1.21||$56.52 million||$58.30 million||View||N/A|
|8/5/2015||Q215||$1.16||$1.15||$55.51 million||$56.31 million||View||N/A|
|5/7/2015||Q115||$1.13||$1.13||$156.00 million||$55.75 million||View||N/A|
|2/17/2015||Q414||$1.06||$1.06||$46.90 million||$45.70 million||View||N/A|
|11/3/2014||Q314||$1.05||$1.05||$43.90 million||$44.50 million||View||N/A|
|8/4/2014||Q214||$1.05||$1.05||$42.77 million||$43.10 million||View||N/A|
|5/5/2014||Q114||$1.01||$1.05||$42.76 million||$43.14 million||View||N/A|
|2/18/2014||Q413||$0.88||$0.90||$31.72 million||$32.79 million||View||N/A|
|8/7/2013||Q213||$0.89||$0.87||$29.37 million||$28.05 million||View||N/A|
|5/6/2013||Q113||$0.80||$0.85||$27.17 million||$28.07 million||View||N/A|
|2/14/2013||Q412||$0.83||$0.84||$25.01 million||$26.82 million||View||N/A|
|11/5/2012||Q312||$0.79||$0.80||$22.51 million||$25.51 million||View||N/A|
Earnings Estimates for National Health Investors (NYSE:NHI)
2017 EPS Consensus Estimate: $5.25
2018 EPS Consensus Estimate: $5.54
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Current Dividend Information for National Health Investors (NYSE:NHI)
|Dividend Growth:||7.80% (3 Year Average)|
|Payout Ratio:||97.69% (Trailing 12 Months of Earnings) |
98.45% (Based on This Year's Estimates)
102.15% (Based on Next Year's Estimates)
|Track Record:||7 Years of Consecutive Dividend Growth|
Dividend History by Quarter for National Health Investors (NYSE NHI)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for National Health Investors (NYSE:NHI)
Insider Ownership Percentage: 5.19%Insider Trades by Quarter for National Health Investors (NYSE:NHI)
Institutional Ownership Percentage: 70.11%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/28/2017||Robert A Mccabe Jr||Director||Buy||259||$79.94||$20,704.46|| |
|8/24/2017||Kevin Carlton Pascoe||Insider||Sell||2,000||$79.80||$159,600.00|| |
|8/30/2016||Robert A Mccabe Jr||Director||Sell||800||$80.29||$64,232.00|| |
|6/29/2016||Kristin Sallee Gaines||Insider||Sell||8,652||$73.98||$640,074.96|| |
|6/28/2016||Kristin Sallee Gaines||Insider||Sell||4,044||$73.71||$298,083.24|| |
|6/13/2016||Robert A Mccabe Jr||Director||Sell||1,250||$71.61||$89,512.50|| |
|5/10/2016||Kevin Carlton Pascoe||EVP||Sell||2,000||$70.72||$141,440.00|| |
|3/28/2016||Roger R Hopkins||CAO||Sell||10,000||$65.45||$654,500.00|| |
|12/11/2015||Robert A Mccabe Jr||Director||Buy||35||$59.10||$2,068.50|| |
|11/17/2015||D. Eric Mendelsohn||CEO||Buy||1,000||$56.12||$56,120.00|| |
|8/26/2015||W Andrew Adams||Director||Buy||2,000||$55.50||$111,000.00|| |
|8/25/2015||Robert T Webb||Director||Buy||5,000||$56.75||$283,750.00|| |
|5/13/2015||D. Eric Mendelsohn||EVP||Buy||1,500||$65.77||$98,655.00|| |
|8/29/2014||Robert A Mccabe Jr||Director||Buy||180||$64.41||$11,593.80|| |
|8/6/2014||James Justin Hutchens||CEO||Buy||2,040||$61.40||$125,256.00|| |
|6/24/2014||James R Jobe||Director||Buy||1,000||$63.47||$63,470.00|| |
|6/3/2013||James Justin Hutchens||CEO||Buy||1,610||$62.23||$100,190.30|| |
|2/22/2013||Kristin Sallee Gaines||Insider||Sell||7,409||$65.97||$488,771.73|| |
Headline Trends for National Health Investors (NYSE:NHI)
Latest Headlines for National Health Investors (NYSE:NHI)
Loading headlines, please wait.
National Health Investors (NHI) Chart for Sunday, October, 22, 2017